Outcome of Idiopathic Macular Hole

Long-term Outcome of Idiopathic Macular Hole Surgery

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00941291

Enrollment

135

Registered

2009-07-17

Start date

2002-01-31

Completion date

2005-01-31

Last updated

2009-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Macular Hole

Keywords

idiopathic macular hole, cataract, edema, Reopening

Brief summary

The purpose of this study is to evaluate the role of cataract surgery and cystoid macular edema (CME) on reopening of idiopathic macular holes (IMH).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Patients with with stage 2, 3, or 4 Idiopathic Macular Hole after successful Idiopathic Macular Hole repair

Exclusion criteria

* All patients without stage 2, 3, or 4 Idiopathic Macular Hole repair

Design outcomes

Primary

Measure	Time frame
Long-term outcome of idiopathic macular hole surgery	37 months

Countries

France

Outcome results